Осложнения и нарушения мочеиспускания после проведенного оперативного лечения ДГПЖ методом лазерной энуклеации

Осложнения и нарушения мочеиспускания после проведенного оперативного лечения ДГПЖ методом лазерной энуклеации

Автор: Котов С.В., Богданов Д.А., Юсуфов А.Г., Гуспанов Р., Мамаев И.Э.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Андрология

Статья в выпуске: 3 т.17, 2024 года.

Бесплатный доступ

Введение. Доброкачественная гиперплазия предстательной железы (ДГПЖ) является распространенным заболеванием у мужчин пожилого возраста, проявляющимся симптомами нарушения функции нижних мочевыводящих путей (СНМП). Медикаментозное лечение ДГПЖ часто позволяет отсрочить или даже избежать выполнения оперативного вмешательства. Современным «золотым стандартом» хирургического лечения ДГПЖ можно считать лазерную эндоскопическую энуклеацию, которая показывает отличные функциональные результаты независимо от возраста пациента, объема предстательной железы. Тем не менее, осложнения и нарушения мочеиспускания после оперативного лечения также присущи данному методу. Целью данной статьи стала систематизация информации по качеству мочеиспускания и сохранению СНМП у пациентов после эндоскопической энуклеации ДГПЖ.

Еще

Доброкачественная гиперплазия предстательной железы, энуклеация, симптомы нижних мочевыводящих путей

Короткий адрес: https://sciup.org/142243279

IDR: 142243279   |   DOI: 10.29188/2222-8543-2024-17-3-86-93

Список литературы Осложнения и нарушения мочеиспускания после проведенного оперативного лечения ДГПЖ методом лазерной энуклеации

  • Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008;20 Suppl 3:S11-8. https://doi.org/10.1038/ijir.2008.55.
  • Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989;2:33-50. https://doi.org/10.1002/pros.2990150506.
  • Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132(3):474-9. https://doi.org/10.1016/s0022-5347(17)49698-4.
  • Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UK. BJU Int 2015;115(4):508-19. https://doi.org/10.1111/bju.12745.
  • Gravas S C.J.D.M. et al. Management of Non-neurogenic Male LUTS. [Electronic resource]. URL: www.eau.org.
  • Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67(6):1099-1109. https://doi.org/10.1016/j.eururo.2014.12.038.
  • Kabalin JN. Holmium:YAG laser prostatectomy: results of U.S. pilot study. J Endourol 1996;10(5):453-7. https://doi.org/10.1089/end.1996.10.453.
  • Gilling PJ, Cass CB, Cresswell MD, Fraundorfer MR. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996;47(1):48-51. https://doi.org/10.1016/s0090-4295(99)80381-1.
  • Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998;33(1):69-72. https://doi.org/10.1159/000019535.
  • Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M. Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol 2009;61(3):309-24.
  • Glybochko PV, Alyaev YuG, Rapoport LM, Enikeev DV, Enikeev ME, Spivak LG, et al. Development of laser technologies in surgical treatment of prostatic hyperplasia. Urol & Androl 2017;5(4):30-6. https://doi.org/10.20953/2307-6631-2017-4-30-36.
  • Vincent MW, Gilling PJ. HoLEP has come of age. World J Urol 2015;33(4):487-93. https://doi.org/10.1007/s00345-014-1443-x.
  • Das AK, Han TM, Hardacker TJ. Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia. Can J Urol 2020;27(S3):44-50.
  • Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol 2011;186(5):1972-6. https://doi.org/10.1016/j.juro.2011.06.065.
  • Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new «gold standard». Urology 2005;66(5 Suppl):108-13. https://doi.org/10.1016/j.urology.2005.06.006.
  • Martin AD, Nunez RN, Humphreys MR. Bleeding after holmium laser enucleation of the prostate: lessons learned the hard way. BJU Int 2011;107(3):433-7. https://doi.org/10.1111/j.1464-410x.2010.09560.x.
  • Romero-Otero J, García-González L, García-Gómez B, Justo-Quintas J, García-Rojo E, González-Padilla DA, et al. Factors influencing intraoperative blood loss in patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia: a large multicenter analysis. Urology 2019;132:177-82. https://doi.org/10.1016/ j.urology.2019.06.024.
  • Hines L, Doersch KM, Ninomiya M, Jain R, Quarrier SO. Redefining clinically significant hematuria after holmium enucleation of the prostate. J Endourol 2023;37(11):1216-20. https://doi.org/10.1089/end.2023.0317.
  • Мартов А. Г., Меринов Д. С., Корниенко С. И. Послеоперационные урологические осложнения трансуретральных электро-хирургических вмешательств на предстательной железе по поводу аденомы. Урология 2006;2:25-32. [Martov A. G., Merinov D. S., Kornienko S. I. Postoperative urological complications of transurethral electrosurgical interventions on the prostate gland for adenoma. Urologiya = Urologyiia 2006;2:25-32. (In Russian)].
  • Assmus MA, Lee MS, Large T, Krambeck AE. Understanding holmium laser enucleation of the prostate (HoLEP) recovery: Assessing patient expectations and understanding. Can Urol Assoc J 2022;16(1):E25-E31. https://doi.org/10.5489/cuaj.7328.
  • Capogrosso P, Fallara G, Pozzi E, Schifano N, Candela L, Costa A, et al. Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center. Minerva Urol Nephrol 2022;74(4):461-6. https://doi.org/10.23736/s2724-6051.21.04315-9.
  • Kyono Y, Endo F, Shimbo M, Ohwaki K, Hattori K. Positive urine culture under indwelling urethral catheterization is a risk factor for febrile complications after holmium laser enucleation of the prostate (HoLEP). Low Urin Tract Symptoms 2021;13(3):377-82. https://doi.org/10.1111/luts.12380.
  • Elsaqa M, Dowd K, El Mekresh A, Doersch KM, El Tayeb MM. Predictors of postoperative urinary tract infection following holmium laser enucleation of the prostate. Can Urol Assoc J 2023;17(11):E364-E368. https://doi.org/10.5489/cuaj.8269.
  • Das AK, Teplitsky S, Chandrasekar T, Perez T, Guo J, Leong JY, Shenot PJ. Stress Urinary Incontinence post-Holmium Laser Enucleation of the Prostate: a Single-Surgeon Experience. Int Braz J Urol 2020;46(4):624-31. https://doi.org/10.1590/s1677-5538.ibju.2019.0411.
  • Enikeev D, Taratkin M, Babaevskaya D, Morozov A, Petov V, Sukhanov R, et al. Randomized prospective trial of the severity of irritative symptoms after HoLEP vs ThuFLEP. World J Urol 2022;40(8):2047-53. https://doi.org/10.1007/s00345-022-04046-8.
  • Cracco C, Ingrosso M, Russo N, Scoffone C. Postoperative dysuria after highand low-power en-bloc no-touch HoLEP. Eur Urol Suppl 2017;16(3):e500–e501. http://dx.doi.org/10.1016/S1569-9056(17)30356-1.
  • Elshal AM, El-Nahas AR, Ghazy M, Nabeeh H, Laymon M, Soltan M, et al. Low-Power Vs High-Power Holmium Laser Enucleation of the prostate: critical assessment through randomized trial. Urology 2018;121:58-65. https://doi.org/10.1016/j.urology.2018.07.010.
  • Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urol 1994;152(3):935-7. https://doi.org/10.1016/s0022-5347(17)32614-9.
  • Тарасов Н.И., Иващенко В.А. Лечение расстройств мочеиспускания после трансуретральной резекции предстательной железы. Экспериментальная и клиническая урология 2016;1:98-105. [Tarasov N.I., Ivaschenko V.A. Treatment of urination disorders after transurethral resection of the prostate gland. Eksperimental'naya i klinicheskaya urologiya = Experimental and Clinical Urology 2016;1:98-105. (In Russian)].
  • Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Predictive factors for postoperative medication therapy for overactive bladder symptoms after holmium laser enucleation of prostate. Int J Urol 2023;30(11):1036-43. https://doi.org/10.1111/iju.15260.
  • Jeong HJ, Lee H, Choo MS, Cho SY, Jeong SJ, Oh SJ. Effect of detrusor underactivity on surgical outcomes of holmium laser enucleation of the prostate. BJU Int 2024;133(6):770-7. https://doi.org/10.1111/bju.16346.
  • Soysal P, Cao C, Xu T, Yang L, Isik AT, Turan Kazancioglu R, et al. Trends and prevalence of nocturia among US adults, 2005-2016. Int Urol Nephrol 2020;52(5):805-13. https://doi.org/10.1007/s11255-019-02361-5.
  • Lv K, Wu Y, Huang S, Luo Z, Lai W, Meng Q, et al. Age and metabolic syndrome are associated with unsatisfactory improvement in nocturia after holmium laser enucleation of the prostate. Front Surg 2023;9:1063649. https://doi.org/10.3389/fsurg.2022.1063649.
  • Fallara G, Capogrosso P, Schifano N, Costa A, Candela L, Cazzaniga W, et al. Ten-year follow-up results after holmium Laser Enucleation of the prostate. Eur Urol Focus 2021;7(3):612-7. https://doi.org/10.1016/j.euf.2020.05.012.
  • Imai K, Negoro H, Takashima Y, Goto T, Sawada A, Akamatsu S, et al. Post-operative urethral stricture after Holmium Laser Enucleation of the prostate. Hinyokika Kiyo 2019;65(11):445-9. https://doi.org/10.14989/actauroljap_65_11_445.
  • Elkoushy MA, Elshal AM, Elhilali MM. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis. J Endourol 2015;29(7):797-804. https://doi.org/10.1089/end.2015.0060.
  • Logie J, Clifford GM, Farmer RD. Incidence, prevalence and management of lower urinary tract symptoms in men in the UK. BJU Int 2005;95(4):557-62. https://doi.org/10.1111/j.1464410x.2005.05339.x.
  • Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Sci Rep 2017;7(1):7984. https://doi.org/10.1038/s41598-017-06628-8.
  • Hahn RG, Nilsson A, Farahmand BY, Persson PG. Blood haemoglobin and the long-term incidence of acute myocardial infarction after transurethral resection of the prostate. Eur Urol 1997;31(2):199-203. https://doi.org/10.1159/000474450.
  • Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, Koshiba K. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999;53(1):98-105. https://doi.org/10.1016/s0090-4295(98)00524-x.
  • Morozov A, Taratkin M, Shpikina A, Ehrlich Y, McFarland J, Dymov A, et al. Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis. World J Urol 2023;41(12):3471-83. https://doi.org/10.1007/s00345-023-04666-8.
  • Tyson MD, Lerner LB. Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol 2009;23(8):1343-6. https://doi.org/10.1089/end.2009.0013.
  • ani H, Esdaille A, Weiss JP. Nocturia: aetiology and treatment in adults. Nat Rev Urol 2016;13(10):573-83. https://doi.org/10.1038/nrurol.2016.134.
  • Ueki H, Takahashi K, Yasufuku T, Yuen K, Yamashita M. Is the membranous urethral length related to postoperative urinary incontinence after holmium laser enucleation of the prostate? Int J Urol 2020;27(10):893-8. https://doi.org/10.1111/iju.14322.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp